CatalystPit

TENXTENAX THERAPEUTICS, INC.

NASDAQ · Pharmaceutical Preparations
Last close $1.89 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$70.73M
RECENT INSIDER TRADES
  • 2026-09-17 · Doogan Declan (Director) · BUY
  • 2026-09-15 · Giordano Christopher Thomas (CEO) · BUY
  • 2026-09-15 · STAAB THOMAS R II (Chief Financial Officer) · BUY
  • 2026-09-08 · ADAR1 Capital Management, LLC (10% Owner) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders116
Shares held32,524,947
Value$466.16M
Percent of shares outstanding86.91%
As of quarter end2026-06-30
RECENT NEWS
  • Tenax Therapeutics director Declan Doogan buys $101,760 in shares
  • Tenax Therapeutics CEO Christopher Giordano acquires $20,087 in shares
  • Tenax Therapeutics CFO buys $10,981 in common stock
  • TENAX THERAPEUTICS, INC. · 8-K (7.01,9.01)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
TENAX THERAPEUTICS, INC. (TENX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit